You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary dose

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • hetrombopag 5mg po qd
  • High-dose Dexamethasone
  • (no location specified)
Jul 5, 2023

Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe

Not yet recruiting
  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia
  • Bempedoic acid and/or its fixed dose combination with ezetimibe
  • (no location specified)
Mar 23, 2023

Primary CNS Lymphoma Trial in Paris (Glucarpidase, Methotrexate (MTX))

Recruiting
  • Primary Central Nervous System Lymphoma
  • Paris, France
    Hôpital Pitié-Salpêtrière
Oct 24, 2022

Japanese Encephalitis Trial in Hoa Binh (Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®))

Completed
Has Results
  • Japanese Encephalitis
  • Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®)
  • Hoa Binh, Vietnam
    Preventive Medicine Centre of Hoa Binh Province
Mar 21, 2022

Primary IgA Nephropathy Trial (SHR-2010 Injection, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • SHR-2010 Injection
  • Placebo
  • (no location specified)
Apr 27, 2023

Efficacy of Fixed Dose Combination Therapy With Atorvastatin and

Enrolling by invitation
  • Primary Hypercholesterolemia
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Nov 4, 2022

    Tumor, Ovarian, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer Trial (AVB-001 (Dose Escalation Phase), AVB-001 (Dose

    Not yet recruiting
    • Neoplasm, Ovarian
    • +7 more
    • AVB-001 (Dose Escalation Phase)
    • AVB-001 (Dose Expansion Phase)
    • (no location specified)
    Sep 15, 2022

    Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Histamine Dihydrochloride (HDC)
    • Interleukin-2 (IL-2)
    • (no location specified)
    Mar 31, 2023

    Ticagrelor Trial (Ticagrelor 60mg)

    Not yet recruiting
    • Ticagrelor
    • Ticagrelor 60mg
    • (no location specified)
    Apr 25, 2023

    Glaucoma Open-Angle Primary, Ocular Hypertension Trial in Albany (H-1337 0.6%, H-1337 1.0%, H-1337 Placebo)

    Not yet recruiting
    • Glaucoma Open-Angle Primary
    • Ocular Hypertension
    • H-1337 0.6%
    • +3 more
    • Albany, Georgia
      Dixon Eye Care
    Jun 12, 2023

    Kidney Disease Trial run by the NIDDK (N-acetyl D-mannosamine)

    Completed
    • Kidney Disease
    • N-acetyl D-mannosamine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    SARS-CoV-2 Trial (CV0701 Bivalent High dose, CV0701 Bivalent Medium dose, CV0701 Bivalent Low dose)

    Not yet recruiting
    • SARS-CoV-2
    • CV0701 Bivalent High dose
    • +4 more
    • (no location specified)
    Jul 24, 2023

    Primary Mitochondrial Disease Trial in Copenhagen, Cambridge (KL1333, Placebo)

    Recruiting
    • Primary Mitochondrial Disease
    • Copenhagen, Denmark
    • +1 more
    Jan 27, 2023

    Primary CNS Lymphoma Trial in Shanghai (Orelabrutinib, Rituximab, Methotrexate (MTX))

    Recruiting
    • Primary Central Nervous System Lymphoma
    • Shanghai, Shanghai, China
      Department of Hematology, Huashan Hospital, Fudan University
    Jul 26, 2022

    Prosthetic Joint Infection Trial in Philadelphia (TNP-2092)

    Completed
    • Prosthetic Joint Infection
    • Philadelphia, Pennsylvania
      Rothman Orthopedic Institute
    Oct 18, 2022

    Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Sep 18, 2023

    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Denmark, Norway, Sweden (KAND567, Carboplatin)

    Recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • Odense, Denmark
    • +3 more
    Oct 16, 2023

    COVID-19 Trial in Jinan (HS-10517 Dose 1, HS-10517 Dose 2, HS-10517 Dose 3)

    Recruiting
    • COVID-19
    • HS-10517 Dose 1
    • +4 more
    • Jinan, Shandong, China
      The First Affiliated Hospital of Shandong First Medical Universi
    Mar 9, 2023

    Dengue Fever, Dengue Hemorrhagic Fever Trial in Colombia, Philippines (CYD Dengue Vaccine, Placebo (Sodium chloride 0.9%))

    Completed
    Has Results
    • Dengue Fever
    • Dengue Hemorrhagic Fever
    • CYD Dengue Vaccine
    • Placebo (Sodium chloride 0.9%)
    • Barranquilla, Colombia
    • +5 more
    Mar 15, 2022

    Breast Cancer Trial in Sheung Shui (Subpectoral plexus block (low dose), Subpectoral plexus block (High dose))

    Not yet recruiting
    • Breast Cancer
    • Subpectoral plexus block (low dose)
    • Subpectoral plexus block (High dose)
    • Sheung Shui, New Territories, Hong Kong
      North District Hospital
    Dec 5, 2022

    Hypertriglyceridemia, Familial Trial in Nanjing (GC304)

    Not yet recruiting
    • Hypertriglyceridemia, Familial
    • GC304
    • Nanjing, China
      Affiliated Jinling Hospital, Medical School, Nanjing University
    May 5, 2023

    CNS Lymphoma Trial in Essen ([90Y]Y-PentixaTher)

    Recruiting
    • CNS Lymphoma
    • Essen, Germany
      University Hospital Essen
    Nov 16, 2023

    Analgesia, Surgery, Cancer of Head and Neck Trial in Copenhagen (Dexamethasone, Placebo)

    Active, not recruiting
    • Analgesia
    • +6 more
    • Copenhagen, Denmark
      Department of Otorhinolaryngology, Head and Neck Surgery & Audio
    Oct 14, 2022

    Metastatic Tumor to the Spine, Metastatic Tumor Trial in Cleveland (Conventional external beam radiation therapy dose (EBRT),

    Recruiting
    • Metastatic Neoplasm to the Spine
    • Metastatic Neoplasm
    • Conventional external beam radiation therapy dose (EBRT)
    • +2 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 24, 2023

    High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

    Not yet recruiting
    • High Grade Serous Adenocarcinoma of Ovary
    • +3 more
    • (no location specified)
    Oct 13, 2023